GlaxoSmithKline (GSK)

Member

GlaxoSmithKline (GSK) Sustainability Profile

GlaxoSmithKline (GSK) is not currently tracking sustainability.

GSK is a focused biopharma company committed to environmental, social and governance (ESG) impacts across its operations, from laboratory to patient. The company has established ambitious sustainability goals aligned with its Trust priority, addressing climate and nature through long-term environmental sustainability targets published across multiple ESG and responsibility reports.

About GlaxoSmithKline (GSK)

  • Status
  • Unverified

GlaxoSmithKline (GSK) Sustainability Actions

Ranked 1st in Access to Medicines

GSK ranked 1st in the Access to Medicines Index for the 8th consecutive time.

Ranked 2nd in ESG Performance

GSK ranked 2nd in ESG performance metrics.

GlaxoSmithKline (GSK) Sustainability Commitments

2030

Net Zero Climate Impact

Reduce carbon emissions by 80% with the remainder offset through investment in high-quality nature-based solutions, and achieve net zero impact on climate.

2030

Net Positive Impact on Nature

Achieve net positive impact on nature by 2030.

2045

Full Net Zero Achievement

Achieve net zero status by 2045.


About GlaxoSmithKline (GSK)

  • Status
  • Unverified

Sustainable Development Goals

GlaxoSmithKline (GSK) is committed to advancing these Global Goals to promote prosperity for people & planet.

 Logo

This information references https://www.gsk.com/ and was sourced on 19/07/2023. Is this your business? Suggest an edit

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.